Across the world, rising costs of cancer care have prompted the development of alternative payment models to fee-for-service, to improve quality and manage healthcare spending. Bundled payments have been implemented in several countries for an array of acute and chronic conditions, including cancer, demonstrating an overall positive impact on spending and quality, but the results can vary. Lessons from the successes and failures of bundled payments can assist in their wider implementation, but information regarding their characteristics, design and context are not always well described. Without clear reporting it is difficult to ascertain which bundles of care are effective for specific patient populations or providers.
Objectives: Review and summarise the current evidence of bundled payment models in cancer care and develop a checklist to inform optimal reporting of bundled payments to assist in transferability to other contexts, with particularly for the Australian setting.
Data/Methods: The literature review conducted by Nejati et al 2019, is being reviewed and repeated. We assess the quality of the articles is being assessed using the Cochrane Effective Practice and Organisation of Care Review Group (EPOC) data collection checklist. We are developing to help inform the optimal reporting of bundled payment arrangements.